NEW YORK--(BUSINESS WIRE)--Abraham, Fruchter & Twersky, LLP (“AF&T” or the “Firm”) has been retained to investigate claims which may be brought on behalf of investors who purchased Sunesis Pharmaceuticals, Inc. (“SNSS” or the “Company”) (NASDAQ: SNSS) during the period of March 12, 2015 through July 23, 2015. On July 23rd, SNSS surprised investors by announcing that the Food and Drug Administration (“FDA”) would not support the filing of a New Drug Application (“NDA”) based upon the dat
| < Prev | Next > |
|---|
